| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/07/2008 | CA2551578A1 Lignan complex derived from flax seed used for treatment of hypercholesterolemic atherosclerosis |
| 01/06/2008 | CA2563116A1 Methods for treating or preventing anemia or thrombocytopenia using a triheterocyclic compound |
| 01/03/2008 | WO2008003093A2 Pharmaceutical compositions and related methods of treatment |
| 01/03/2008 | WO2008003028A2 Pharmaceutical compositions comprising droxidopa |
| 01/03/2008 | WO2008003013A2 Antitumorigenic drug combination comprising an hdac inhibitor and a tsp-1 peptidomimetic |
| 01/03/2008 | WO2008003007A2 Compositions and methods for treating parasitic infections |
| 01/03/2008 | WO2008002974A1 Pyrrole derivatives and their methods of use |
| 01/03/2008 | WO2008002946A2 Method of modulating neurite outgrowth by the use of a galanin-3 receptor antagonist |
| 01/03/2008 | WO2008002929A2 Heterologous cross-sensitization for improved agonist activity |
| 01/03/2008 | WO2008002924A2 Quinoxalinyl macrocyclic hepatitis c virus serine protease inhibitors |
| 01/03/2008 | WO2008002905A2 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same |
| 01/03/2008 | WO2008002894A1 Chemotherapeutic compounds for selectively targeting tumor cells with fr type receptors |
| 01/03/2008 | WO2008002862A1 Organic compounds |
| 01/03/2008 | WO2008002853A2 Phenylacetic acid derivatives as cox-2 inhibitors |
| 01/03/2008 | WO2008002849A2 Aryl sulfones |
| 01/03/2008 | WO2008002824A1 Crystalline solvates and complexes of (is) -1, 5-anhydro-l-c- (3- ( (phenyl) methyl) phenyl) -d-glucitol derivatives with amino acids as sglt2 inhibitors for the treatment of diabetes |
| 01/03/2008 | WO2008002820A2 Substituted benzyl amine compounds |
| 01/03/2008 | WO2008002818A1 Substituted aminomethyl benzamide compounds |
| 01/03/2008 | WO2008002817A1 Butyl and butynyl benzyl amine compounds |
| 01/03/2008 | WO2008002816A1 Substituted benzamide modulators of the histamine h3 receptor |
| 01/03/2008 | WO2008002777A2 An anti-viral composition for the topical treatment of herpes labialis (cold sores) and method for use thereof |
| 01/03/2008 | WO2008002683A2 Polymorphous forms of carvedilol phosphate |
| 01/03/2008 | WO2008002674A2 Bicyclic compositions and methods for modulating a kinase cascade |
| 01/03/2008 | WO2008002655A2 Crystalline forms of atorvastatin |
| 01/03/2008 | WO2008002641A2 Protein phosphatase inhibitors |
| 01/03/2008 | WO2008002634A1 Use of hdac inhibitors for the treatment of lymphomas |
| 01/03/2008 | WO2008002629A1 Process for the preparation of zopiclone |
| 01/03/2008 | WO2008002621A2 Benzyl-substituted quinolone m1 receptor positive allosteric modulators |
| 01/03/2008 | WO2008002611A2 Delta-tocotrienol treatment and prevention of pancreatic cancer |
| 01/03/2008 | WO2008002602A1 Use of n-desmethylclozapine to treat psychosis |
| 01/03/2008 | WO2008002594A2 Neuronal circuit-dependent neuroprotection by interaction between nicotinic receptors |
| 01/03/2008 | WO2008002583A1 Glycine transporter-1 inhibitors |
| 01/03/2008 | WO2008002582A2 Ultraviolet absorbing ophthalmic compositions |
| 01/03/2008 | WO2008002576A2 Prolyl hydroxylase inhibitors and methods of use |
| 01/03/2008 | WO2008002575A1 Melanin concentrating hormone antagonists |
| 01/03/2008 | WO2008002573A2 Bile acid derivatives as fxr ligands for the prevention or treatment of fxr-mediated deseases or conditions |
| 01/03/2008 | WO2008002571A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008002570A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008002569A2 Human protein tyrosine phosphatase inhibitors and methods of use |
| 01/03/2008 | WO2008002568A2 Active agent formulations, methods of making, and methods of use |
| 01/03/2008 | WO2008002567A2 Methods of treating conditions by sustained release administration of benzimidazole derivatives |
| 01/03/2008 | WO2008002544A2 Unit dosage forms of temozolomide |
| 01/03/2008 | WO2008002539A1 Combinations comprising 5ht6 modulators and cholinesterase inhibitors |
| 01/03/2008 | WO2008002514A2 Combination cough treatment compounds and method of treating common coughs |
| 01/03/2008 | WO2008002485A2 Increased amorphous stability of poorly water soluble drugs by nanosizing |
| 01/03/2008 | WO2008002465A2 INHIBITORS OF Aβ AND SYNUCLEIN AGGREGATION |
| 01/03/2008 | WO2008002460A2 Orally available light-independent antineoplastic compounds |
| 01/03/2008 | WO2008002449A2 Glycomimetic inhibitors of siglec-8 |
| 01/03/2008 | WO2008002283A2 Therapies and compositions for controlling the stress mechanism and for stabilizing hemostasis in an organism |
| 01/03/2008 | WO2008002247A1 New pyridine analogues |
| 01/03/2008 | WO2008002246A1 A pharmaceutical composition comprising an ikk2 inhibitor and a second active ingrdient. |
| 01/03/2008 | WO2008002245A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 01/03/2008 | WO2008002244A2 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 01/03/2008 | WO2008002196A1 Pharmaceutical composition for treating burns (variants) and a method for the production thereof (variants) |
| 01/03/2008 | WO2008002118A1 An ophthalmic formulation in suspension of loteprednol etabonate and ciprofloxacin hydrochloride |
| 01/03/2008 | WO2008002117A1 Ophthalmic solution of ciprofloxacin and dexamethasone |
| 01/03/2008 | WO2008002039A1 Quinazoline derivatives for inhibiting the growth of cancer cell |
| 01/03/2008 | WO2008001959A1 Novel 6-5 bicycic heterocyclic derivative and medical use thereof |
| 01/03/2008 | WO2008001956A1 Therapeutic agent for liver fibrosis |
| 01/03/2008 | WO2008001931A2 Fused cyclic compounds |
| 01/03/2008 | WO2008001930A1 Pyridylisoxazole derivative |
| 01/03/2008 | WO2008001929A1 Treatment agent for inflammatory bowel disease |
| 01/03/2008 | WO2008001921A2 Dermatological anti-wrinkle agent |
| 01/03/2008 | WO2008001912A1 Substituted benzyl ester derivative and use thereof |
| 01/03/2008 | WO2008001886A1 Aurora inhibitor |
| 01/03/2008 | WO2008001885A1 Abl KINASE INHIBITOR |
| 01/03/2008 | WO2008001884A1 Antiarteriosclerosis agents |
| 01/03/2008 | WO2008001883A1 α-AMINO ACID DERIVATIVE AND PHARMACEUTICAL COMPRISING THE SAME AS ACTIVE INGREDIENT |
| 01/03/2008 | WO2008001878A1 Hydroxy ether compound, process for production of the compound, and use of the compound |
| 01/03/2008 | WO2008001872A1 Ophthalmic composition containing alginic acid or salt thereof |
| 01/03/2008 | WO2008001864A1 C-phenyl 1-thioglucitol compound |
| 01/03/2008 | WO2008001859A1 OPIOID δ RECEPTOR AGONIST |
| 01/03/2008 | WO2008001851A1 Drug, drug induction device, magnetic detector and method of designing drug |
| 01/03/2008 | WO2008001800A1 Tooth enamel dissolution inhibitor |
| 01/03/2008 | WO2008001770A1 Antiallergic composition and agent, and food, beverage and animal feed each containing the composition or agent |
| 01/03/2008 | WO2008001769A1 Intestinal immunity-activating substance or agent, and food, beverage and animal feed containing the same |
| 01/03/2008 | WO2008001752A1 Treatment of chronic obstructive pulmonary disease by statin |
| 01/03/2008 | WO2008001734A1 Compressed preparation |
| 01/03/2008 | WO2008001553A1 Ozonized surfactant |
| 01/03/2008 | WO2008001502A1 Potentiator of radiation therapy |
| 01/03/2008 | WO2008001499A1 Prophylactic and/or therapeutic agent for rheumatoid arthritis |
| 01/03/2008 | WO2008001495A1 Agent against psychosocial stresses |
| 01/03/2008 | WO2008001494A1 Pharmaceutical agent for prevention of fatigue and/or recovery from fatigue |
| 01/03/2008 | WO2008001491A1 Antiallergic agent |
| 01/03/2008 | WO2008001391A2 Site-specific inhibitors of histone methyltransferase [hmtase] and process of preparation thereof |
| 01/03/2008 | WO2008001389A2 Female contraceptive for transcervical delivery and its' preparation |
| 01/03/2008 | WO2008001369A1 Use of cb2 receptor agonists for promoting neurogenesis |
| 01/03/2008 | WO2008001368A2 Use of stilbene derivatives for treatment and prevention of aquatic mold infections |
| 01/03/2008 | WO2008001311A2 Pharmaceutical composition containing fixed dose combination of atenolol with isosorbide mononitrate |
| 01/03/2008 | WO2008001294A2 High dose oral pharmaceutical compositions of artemether and lumefantrine |
| 01/03/2008 | WO2008001240A2 Transdermal delivery of oleocanthal for relief of inflammation |
| 01/03/2008 | WO2008001212A2 Penem prodrugs |
| 01/03/2008 | WO2008001201A2 Pharmaceutical compositions of clopidogrel |
| 01/03/2008 | WO2008001200A2 Transdermal composition having enhanced color stability |
| 01/03/2008 | WO2008001182A1 Tricyclic heteroaryl compounds as pde10 inhibitors |
| 01/03/2008 | WO2008001160A1 Melanin concentrating hormone antagonists |
| 01/03/2008 | WO2008001156A1 CANCER THERAPY USING BcI-XL-SPECIFIC siNA |
| 01/03/2008 | WO2008001151A1 Controlled release compositions of divalproex sodium |
| 01/03/2008 | WO2008001134A1 1,2,3,8,9,9a-hexahydro-7h-benzo(de)-1,7-naphthyridin-7-one derivatives as inhibitors of poly(adp-ribose) polymerase (parp) |
| 01/03/2008 | WO2008001101A2 Pharmaceutical combinations |